Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sun, J.; Pons, J.; Craik, C.S.: Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies. Biochemistry, 42, 892–900 (2003)
Benaud, C.; Dickson, R.B.; Lin, C.Y.: Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Eur. J. Biochem., 268, 1439–1447 (2001)
Lin, C.Y.; Anders, J.; Johnson, M.; Sang, Q.A.; Dickson, R.B.: Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J. Biol. Chem., 274, 18231–18236 (1999)
Lin, C.Y.; Anders, J.; Johnson, M.; Dickson, R.B.: Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J. Biol. Chem., 274, 18237–18242 (1999)
Takeuchi, T.; Harris, J.L.; Huang, W.; Yan, K.W.; Coughlin, S.R.; Craik, C.S.: Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem., 275, 26333–26342 (2000)
Lee, S.L.; Dickson, R.B.; Lin, C.Y.: Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem., 275, 36720–36725 (2000)
Benaud, C.; Oberst, M.; Hobson, J.P.; Spiegel, S.; Dickson, R.B.; Lin, C.Y.: Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase. J. Biol. Chem., 277, 10539–10546 (2002)
Friedrich, R.; Fuentes-Prior, P.; Ong, E.; Coombs, G.; Hunter, M.; Oehler, R.; Pierson, D.; Gonzalez, R.; Huber, R.; Bode, W.; Madison, E.L.: Catalytic domain structures of MT-SP1/matriptase, a matrix-degrading transmembrane serine proteinase. J. Biol. Chem., 277, 2160–2168 (2002)
Oberst, M.D.; Williams, C.A.; Dickson, R.B.; Johnson, M.D.; Lin, C.Y.: The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J. Biol. Chem, 278, 26773–26779 (2003)
List, K.; Szabo, R.; Wertz, P.W.; Segre, J.; Haudenschild, C.C.; Kim, S.Y.; Bugge, T.H.: Loss of proteolytically processed filaggrin caused by epidermal deletion of matriptase/MT-SP1. J. Cell. Biol., 163, 901–910 (2003)
Enyedy, I.J.; Lee, S.L.; Kuo, A.H.; Dickson, R.B.; Lin, C.Y.; Wang, S.: Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase. J. Med. Chem., 44, 1349–1355 (2001)
Szabo, R.; Netzel-Arnett, S.; Hobson, J.P.; Antalis, T.M.; Bugge, T.H.: Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity. Biochem. J., 290, 231–242 (2005)
Oberst, M.D.; Chen, L.L.; Kiyomiya, K.; Williams, C.A.; Lee, M.; Johnson, M.D.; Dickson, R.B.; Lin, C.: HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Am. J. Physiol., 289, C462–C470 (2005)
Tsuzuki, S.; Murai, N.; Miyake, Y.; Inouye, K.; Hirayasu, H.; Iwanaga, T.; Fushiki, T.: Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes. Biochem. J., 388, 679–687 (2005)
Ahmed, S.; Jin, X.; Yagi, M.; Yasuda, C.; Sato, Y.; Higashi, S.; Lin, C.Y.; Dickson, R.B.; Miyazaki, K.: Identification of membrane-bound serine proteinase matriptase as processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25). FEBS J., 273, 615–627 (2006)
Desilets, A.; Longpre, J.M.; Beaulieu, M.E.; Leduc, R.: Inhibition of human matriptase by eglin c variants. FEBS Lett., 580, 2227–2232 (2006)
Ihara, S.; Miyoshi, E.; Nakahara, S.; Sakiyama, H.; Ihara, H.; Akinaga, A.; Honke, K.; Dickson, R.B.; Lin, C.; Taniguchi, N.: Addition of β1–6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin. Glycobiology, 14, 139–146 (2004)
Ito, Y.; Akinaga, A.; Yamanaka, K.; Nakagawa, T.; Kondo, A.; Dickson, R.B.; Lin, C.Y.; Miyauchi, A.; Taniguchi, N.; Miyoshi, E.: Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues — its possible role in prolonged stability in vivo by aberrant glycosylation. Glycobiology, 16, 368–374 (2006)
Suzuki, M.; Kobayashi, H.; Kanayama, N.; Saga, Y.; Suzuki, M.; Lin, C.Y.; Dickson, R.B.; Terao, T.: Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase. J. Biol. Chem., 279, 14899–14908 (2004)
Jin, X.; Hirosaki, T.; Lin, C.Y.; Dickson, R.B.; Higashi, S.; Kitamura, H.; Miyazaki, K.: Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin. J. Cell. Biochem., 95, 632–647 (2005)
Zeng, L.; Cao, J.; Zhang, X.: Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract. World J. Gastroenterol., 11, 6202–6207 (2005)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2009). Matriptase. In: Chang, A. (eds) Class 3 Hydrolases. Springer Handbook of Enzymes, vol S5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85703-7_49
Download citation
DOI: https://doi.org/10.1007/978-3-540-85703-7_49
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-85702-0
Online ISBN: 978-3-540-85703-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)